Improvement of spontaneous alternation behavior deficit by activation of α4β2 nicotinic acetylcholine receptor signaling in the ganglioside GM3-deficient mice

Biomedical Research (Japan)

Volumn 34, Issue 4, 2013, Pages 189-195

  Niimi, Kimie ^a   Nishioka, Chieko ^a   Miyamoto, Tomomi ^b   Akahashi, Eiki ^a   Miyoshi, Ichiro ^b   Itakura, Chitoshi ^a   Amashita, Tadashi ^c,d  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^c AZABU UNIVERSITY   (Japan)

^d Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; DIHYDRO BETA ERYTHROIDINE; GANGLIOSIDE GM3; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR ALPHA4BETA2; PNU 120596; RIVANICLINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DRUG DOSE COMPARISON; MALE; MAZE TEST; MOUSE; NONHUMAN; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TASK PERFORMANCE;

ANIMALS; BEHAVIOR, ANIMAL; G(M3) GANGLIOSIDE; MALE; MICE; MICE, KNOCKOUT; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION;

EID: 84883432794     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.34.189     Document Type: Article

References (25)

1. Arendash GW, Sengstock GJ, Sanberg PR and Kem WR (1995) Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS 21. Brain Res 674, 252-259.
2. Bancroft A and Levin ED (2000) Ventral hippocampal α4β2 nicotinic receptors and chronic nicotine effects on memory. Neuropharmacology 39, 2770-2778.
3. Blondel A, Sanger DJ and Moser PC (2000) Characterisation of the effects of nicotine in the five-choice serial reaction time task in rats: antagonist studies. Psychopharmacology 149, 293-305.
4. Cordero-Erausquin M, Marubio LM, Klink R and Changeux J-P (2000) Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 21, 211-217.
5. Daniotti JL, Crespo PM and Yamashita T (2006) In vivo modulation of epidermal growth factor receptor phosphorylation in mice. J Cell Biochem 99, 1442-1451.
6. Felix R and Levin ED (1997) Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats. Neuroscience 81, 1009-1017.
7. Grottick AJ and Higgins GA (2000) Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 117, 197-208.
8. Hakomori S (1981) Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu Rev Biochem 50, 33-764.
9. Hashimoto K, Koike K, Shimizu E and Iyo M, (2005) alpha7 Nicotinic receptor agonists as potential therapeutic drugs for schizophrenia. Curr Med Chem Cent Nerv Syst Agent 5, 171-184.
10. Hashimoto K, Koike K Shimizu E and Iyo M, (2005) alpha7 Nicotinic receptor agonists as potential therapeutic drugs for schizophrenia. Curr Med Chem Cent Nerv Syst Agent 5, 171-184.
11. Hunter BE, de Fieber CM, Papke RL. Kem WR and Meyer EM 1994 A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci lett 168. 130-131.
12. Kim SM, Jung JU, Ryu JS, Jin JW, Yang HJ, Ko K, You HK, Jung KY and Choo YK (2008) Effects of gangliosides on the differentiation of human mesenchymal stem cells into osteoblasts by modulating epidermal growth factor receptors. Biochem Biophys Res Commun 371, 866-871.
13. Kitagawa H, Takenouchi T, Azuma R, Wesnes KA, Kramer WG, Clody DE and Burnett AL (2003) Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28, 542-551.
14. Levin ED, Bettegowda C, Blosser J and Gordon J (1999) AR-R17779, an alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10, 675-680.
15. Levin ED, McClernon FJ and Rezvani AH (2006) Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology 184, 523-539.
16. Lukas RJ, Changeux JP, Le Novère N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW and Wonnacott S (1999) International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 51, 397-401.
17. Nagafuku M, Okuyama K, Onimaru Y, Suzuki A, Odagiri Y, Yamashita T, Iwasaki K, Fujiwara M, Takamiya M, Ohno I and Inokuchi J (2012) CD4 and CD8 T cells require different membrane gangliosides for activation. Proc Natl Acad Sci USA 109, E336-342.
18. Niimi K, Takahashi E and Itakura C (2008) Improved shortterm memory and increased expression of NR2B observed in senescence-accelerated mouse (SAM) P6. Exp Gerontol 43, 847-452.
19. Niimi K, Nishioka C, Takahashi E, Miyoshi I, Miyamoto T, Itakura C and Yamashita T (2011) Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice. Biochem Biophys Res Commun 406, 524-528.
20. Sarter M, Bodewitz G and Stephens DN (1988) Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl) 94, 491-495.
21. Slotkin TA (2002) Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol 24, 369-384.
22. Ueno KI, Togashi H, Mori K, Matsumoto M, Ohashi S, Hoshino A, Fujita T, Saito H, Minami M and Yoshioka M (2002) Behavioural and pharmacological relevance of stroke prone spontaneously hypertensive rats as an animal model of a developmental disorder. Behav Pharmacol 13, 1-13.
23. van Kampen M, Selbach K, Schneider R, Schiegel E, Boess FG and Schreiber R (2004) AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors. Psychopharmacology 172, 375-383.
24. Wilens TE and Decker MW (2007) Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition. Biochem Pharmacol 74, 1212- 1223.
25. Yamashita T, Hashiramoto A, Haluzik M, Mizukami H, Beck S, Norton A, Kono M, Tsuji S, Daniotti JL, Werth N, Sandhoff R, Sandhoff K and Proia RL (2003) Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA 100, 3445-3449.